Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-04-06

FDA Approved: DAPAGLIFLOZIN AND SAXAGLIPTIN — Original Application (Novadoz Pharmaceuticals LLC)

View source ↗

Summary

FDA approved the original application for a generic fixed-dose combination of dapagliflozin and saxagliptin, manufactured by Novadoz Pharmaceuticals LLC. The pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dapagliflozin and Saxagliptin (dapagliflozin and saxagliptin)

Snippet

ORIG AP for DAPAGLIFLOZIN AND SAXAGLIPTIN (DAPAGLIFLOZIN AND SAXAGLIPTIN)